Advertisement
Screener

Pluri Inc. (PLUR) Accounts Payable, Other, Current

2.8 / 5 stars · 68/120 Roast Me

Pluri Inc. Accounts Payable, Other, Current

Pluri Inc. (PLUR) had Accounts Payable, Other, Current of $1.68 million as of 2026-06-30, per its 10-K filed 2026-09-10.

Financial Statements › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accounts Payable, Current

us-gaap:AccountsPayableOtherCurrent · last filed 2026-09-10

  • 2026-06-30: Accounts Payable, Other, Current $1.68M.
  • 2026-03-31: Accounts Payable, Other, Current $1.38M.
  • 2025-12-31: Accounts Payable, Other, Current $1.43M.
  • 2025-09-30: Accounts Payable, Other, Current $1.32M.
Period endAccounts Payable, Other, CurrentAccounts Payable, Other, Current as first filed
2026-06-30$1.68M
10-K · filed 2026-09-10
2026-03-31$1.38M
10-Q · filed 2026-05-14
2025-12-31$1.43M
10-Q · filed 2026-02-12
2025-09-30$1.32M
10-Q · filed 2025-11-12
2025-06-30$1.33M
10-K · filed 2026-09-10
2025-03-31$1.25M
10-Q · filed 2025-05-13
2024-12-31$1.11M
10-Q · filed 2025-02-11
2024-09-30$1.15M
10-Q · filed 2024-11-12
2024-06-30$963.00K
10-K · filed 2025-09-17
$1.01M
10-K · filed 2024-09-18
2023-06-30$1.10M
10-K · filed 2024-09-18
2022-06-30$1.74M
10-K · filed 2023-09-12
2021-06-30$1.21M
10-K · filed 2022-09-21
$2.42M
10-K · filed 2021-09-13
2020-06-30$1.98M
10-K · filed 2021-09-13
2020-03-31$1.81M
10-Q · filed 2020-05-11
2019-12-31$1.62M
10-Q · filed 2020-02-06
2019-09-30$1.61M
10-Q · filed 2019-11-07
2019-06-30$2.13M
10-K · filed 2020-09-10
2019-03-31$2.01M
10-Q · filed 2019-05-06
2018-12-31$2.23M
10-Q · filed 2019-02-06
2018-09-30$2.22M
10-Q · filed 2018-11-07
2018-06-30$3.02M
10-K · filed 2019-09-12
2018-03-31$3.44M
10-Q · filed 2018-05-09
2017-12-31$2.27M
10-Q · filed 2018-02-06
2017-09-30$1.73M
10-Q · filed 2017-11-07
2017-06-30$1.98M
10-K · filed 2018-09-12
2017-03-31$2.27M
10-Q · filed 2017-05-08
2016-12-31$1.52M
10-Q · filed 2017-02-08
2016-09-30$1.57M
10-Q · filed 2016-11-07
2016-06-30$1.70M
10-K · filed 2017-09-07
2016-03-31$1.68M
10-Q · filed 2016-05-09
2015-12-31$1.50M
10-Q · filed 2016-02-08
2015-09-30$1.29M
10-Q · filed 2015-11-05
2015-06-30$1.53M
10-K · filed 2016-09-07
2015-03-31$1.46M
10-Q · filed 2015-05-06
2014-12-31$1.45M
10-Q · filed 2015-02-05
2014-09-30$1.96M
10-Q · filed 2014-11-06
2014-06-30$2.39M
10-K · filed 2015-09-09
2014-03-31$1.95M
10-Q · filed 2014-05-08
2013-12-31$1.29M
10-Q · filed 2014-02-05
2013-09-30$1.11M
10-Q · filed 2013-11-05
2013-06-30$1.27M
10-K · filed 2014-09-11
2013-03-31$1.06M
10-Q · filed 2013-05-08
2012-12-31$925.00
10-Q · filed 2013-01-31
2012-09-30$729.00K
10-Q · filed 2012-11-06
2012-06-30$877.00K
10-K · filed 2013-09-11
2012-03-31$663.00K
10-Q · filed 2012-05-08
2011-12-31$722.00K
10-Q · filed 2012-02-09
2011-09-30$670.00K
10-Q · filed 2011-11-09
2011-06-30$633.00K
10-K · filed 2012-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Passage BIO, Inc. (PASG)United States$0.015B-0.43
IN8BIO, INC. (INAB)United States$0.012B-0.76
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B